The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes.
NCT: NCT06314061 · COMPLETED
Brief Summary
The goal of this randomised controlled trial to investigate the effect of continuous glucose monitoring (CGM) compared to standard point-of-care (POC) blood glucose measurements in surgical patients with diabetes in patients. The main question it aims to answer is: • Can the use of the CGM device Dexcom G7 with real-time alerts on dysglycaemia increase the time in range for glucose levels as compared with standard monitoring with point-of-care blood glucose in surgical patients with diabetes? Participants will be asked to wear a CGM device (Dexcom G7, Dexcom Inc.) during their stay in the hospital. For patients in the intervention group, deviations of glucose levels will provide the nursing staff with alerts. All patients will receive standard care of their diabetes. The CGM device will be worn for up to 10 days or until discharge.
Frequently Asked Questions
What is The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes.?
The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes. is a clinical trial registered under NCT06314061. Current status: COMPLETED.
What is the status of NCT06314061?
The current status of NCT06314061 (The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes.) is: COMPLETED.
When did The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes. start?
The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes. started on 2024-06-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.